期刊文献+

高危型HPV-DNA联合液基细胞学检测对宫颈癌筛查的价值 被引量:20

Value of combined application of high risk human papillomavirus DNA detection and thinprep cytologic test for cervical cancer screening
在线阅读 下载PDF
收藏 分享 导出
摘要 目的 探究高危型人乳头瘤病毒(high-risk human papillomavirus,HR-HPV)DNA检测联合液基薄层细胞学检测(thinprep cytologic test,TCT)对宫颈癌(cervical cancer,CC)筛查的临床价值。方法 选择经TCT检查异常的宫颈病变患者141例,根据TCT检测结果及宫颈活检结果分级,采用表面等离子谐振法(surface plasmon resonance,SPR)检测HR-HPV-DNA。结果 宫颈活检阳性检出率为65.2%(92/141)明显高于TCT阳性检出率39.0%(55/141)(χ2=19.45,P〈0.05)。HR-HPV-DNA阳性检出率为66.0%(93/141)明显高于TCT阳性检出率39.0%(55/141)(χ2=20.53,P〈0.05)。结论 TCT、HR-HPV-DNA和宫颈活检均为CC重要的筛查方法,TCT联合HR-HPV-DNA检测可提高CC的筛查效率。 Objective To evaluate the diagnostic value of thinprep cytologic test (TCT) combined with high-risk human papillomavirus (HR-HPV) DNA for cervical cancer (CC). Methods 141 cases of patients with abnormal cervical lesions were abnormal examined by TCT and were graded by the results of TCT and cervical biopsy, the HR-HPV-DNA was detected by surface plasmon resonance (SPR). Results The cervical biopsy positive rate 65.2% (92/141) was significantly higher than the positive rate of TCT 39.0% (55/141) ( x^2=19.45, P 〈 0.05). The positive rate of HR-HPV-DNA was 66.0% (93/141) was significantly higher than the positive rate of TCT 39.0% (55/141), =20.53, P 〈 0.05). Conclusion TCT, HR-HPV-DNAand cervical biopsy are important clinical diagnostic methods for cervical lesions, combine detection of TCT and HR-HPV-DNA can improve the detection rate of cervical lesions.
作者 孙蕾蕾 李绍条 林兴园 SUN Lei-lei, LI Shao-tiao, LEST Xing-yuan(Department of Pathology, Cangnan Second People's Hospital, Wenzhou 325802, China)
出处 《中国生化药物杂志》 CAS 2017年第1期283-285,共3页 Chinese Journal of Biochemical Pharmaceutics
基金 温州市苍南县科技计划项目(2013S03)
关键词 液基薄层细胞学检测 HR-HPV-DNA 宫颈活检 宫颈癌 筛查 TCT HR-HPV-DNA cervical biopsy cervical cancer screening
  • 相关文献

参考文献7

二级参考文献60

  • 1纪燕琴,黄凤英.宫颈细胞学涂片配合阴道镜检查对子宫颈病变筛查结果分析[J].中国实用妇科与产科杂志,2004,20(7):419-420. 被引量:20
  • 2魏丽惠.应高度关注子宫颈病变的筛查[J].中国医刊,2007,42(8):2-5. 被引量:27
  • 3Parkin DM. The slobal health burden of infection - associatedcancers in the year 2002[ J]. Int J Cancer, 2006,118(12) : 3030. 被引量:1
  • 4Kuhn L, Denny L,Pollack A, et al. Human papillomavirusDNA testing for cervical cancer screening in low resource set-tings [J]. J Natl Cancer Inst,2000, 92 (10): 818. 被引量:1
  • 5Wright TC,Cox JT,Massad S,et al. 2001 Consensus guide-lines for the management of women with cervical intraepithelialneoplasia[ J]. J Low Genit Tract Dis,2003,1 ( 89 ):295. 被引量:1
  • 6Naucler P,Ryd W,Tomberg S et al. HPV type - specific risks ofhish — grade CIN during 4 years of follow - up : a population —based prospective study[ J]. Br J Cancer,2007,97:129. 被引量:1
  • 7De Cremoux P, Coste J, Sastre - Garau X,et al. Efficiencyof the hybrid capture 2 HPV DNA test in cervical can cerscreening. A study by the French Society of Clinical Cytology[J] . Am J Clin Pathol, 2003,120 (4) : 492-9. 被引量:1
  • 8Tsai HJ, Wu CH, Lai HL,et al. Association between quanti-tative high - risk human papillomavirus DNA load and cervicalintraepithelial neoplasm risk[J]. Cancer Epidemiol Biomark-ers Prev, 2005,14 (11) : 2544. 被引量:1
  • 9Bekkers RL,Massuger LF, Buhen J, et al. Epidemiologicaland clinical aspects of human papillomavirus detection in theprevention of cervical cancer [ J ] . Rev Med Virol, 2004,14: 95. 被引量:1
  • 10Schifman MH,Bauer HM,Hoover RN, et al. Epidemiologyof cervical cacinogenisis[J]. Cancer, 1995,76: 1888. 被引量:1

共引文献300

同被引文献151

引证文献20

二级引证文献29

论文智能改写系统
维普数据出版直通车
投稿分析
职称考试

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈